In January 2017, ERIC formed a partnership with HARMONY, an initiative that aims to create better access and care for patients with various blood diseases by using a big data platform.

This project, which has a duration of five years, consists of a European network of 51 partners, including 44 public partners from 11 different countries. It’s collaborators are key-stakeholders working in distinct fields such as pharmaceutical, clinical and regulatory.

The Harmony Project is funded through the Innovative Medicines Initiative (IMI), which is Europe’s largest public-private initiative aiming to speed up the development of better and safer medicines for patients.


  • Developing a data-sharing platform that empowers clinicians, patients and policy stakeholders to improve decision-making.
  • Establishing a network of European hematological malignancies stakeholders.
  • Defining meaningful and harmonized clinical endpoints and standard outcomes in ALL (pediatric & adult), NHL, MM, AML, CLL, MDS.
  • Aligning key-stakeholders on relevance of these outcomes (policy makers, payers, patients).
  • Providing tools for analyzing complex data sets comprising different layers of information.
  •  Identifying specific markers for early registration of innovative and effective therapies for HMS.

Should you wish to have further information on this project then please contact the Harmony office –